dilluns, 26 de gener del 2015

ANVISA granted more leverage to prioritize medical device-related health risks




The Emergo Group Blog provides short updates on quality and regulatory topics that may be of interest to QA/RA professionals in the medical device and IVD industry. No fluff, just straight to the point. We hope you'll enjoy the content.





Emergo Group

By Stewart Eisenhart, Emergo Group


A new Brazilian law allows ANVISA, the country's medical device market regulator, greater latitude to manage public health risks and surveillance measures in a way that may also boost efficiencies for Brazilian market registrants.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1zNMe7N

Cap comentari:

Publica un comentari a l'entrada